"FDA Takes Action Against Carbadox: Cites Cancer Risk in Pork Industry"

The Food and Drug Administration (FDA) is moving to pull carbadox, a common veterinary drug used by American pork farms, from the market due to concerns that it could pose a cancer risk in humans who consume pork products. Carbadox is added to pig feed to combat infections and promote weight gain. The FDA's decision comes after years of safety concerns and follows actions taken by other countries to restrict the use of the drug. The drug's manufacturer, Phibro Animal Health Corporation, disagrees with the FDA's move and argues that it is based on inadequate science. Pulling carbadox could have significant financial implications for the pork industry and may lead to increased use of other antibiotics, potentially contributing to antimicrobial resistance. Phibro has the option to request a hearing to challenge the FDA's decision.